Analytical and Clinical Performance of Two Point of Care Rapid Antibody Assays for SARS-CoV-2.

Objective: The SARS-CoV-2 pandemic has reached to a state where populations across the world should ad-just to live with it like many other diseases. Regular serosurveys are essential for disease surveil-lance and policy decisions. In this study, we evaluated the analytical and clinical performance of two commercially available rapid antibody assays.